Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Net Margin (2018 - 2025)

Historic Net Margin for Neurogene (NGNE) over the last 5 years, with Q1 2025 value amounting to 28491.25%.

  • Neurogene's Net Margin rose 256572000.0% to 28491.25% in Q1 2025 from the same period last year, while for Sep 2025 it was 108471.25%, marking a year-over-year increase of 1301489600.0%. This contributed to the annual value of 8184.43% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Neurogene reported Net Margin of 28491.25% as of Q1 2025, which was up 256572000.0% from 2014.27% recorded in Q2 2024.
  • In the past 5 years, Neurogene's Net Margin ranged from a high of 408700.0% in Q1 2023 and a low of 2014.27% during Q2 2024
  • Over the past 3 years, Neurogene's median Net Margin value was 15662.65% (recorded in 2024), while the average stood at 109502.76%.
  • Per our database at Business Quant, Neurogene's Net Margin crashed by 2000000000bps in 2024 and then surged by 256572000bps in 2025.
  • Neurogene's Net Margin (Quarter) stood at 408700.0% in 2023, then tumbled by -100bps to 2014.27% in 2024, then soared by 1514bps to 28491.25% in 2025.
  • Its last three reported values are 28491.25% in Q1 2025, 2014.27% for Q2 2024, and 2834.05% during Q1 2024.